ALKERMES INC
10-Q, EX-27, 2000-11-14
PHARMACEUTICAL PREPARATIONS
Previous: ALKERMES INC, 10-Q, 2000-11-14
Next: INTEGRATED CIRCUIT SYSTEMS INC, 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE 10-Q FOR
THE SIX MONTHS ENDED SEPTEMBER 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          MAR-31-2001
<PERIOD-START>                             APR-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          14,325
<SECURITIES>                                   307,095
<RECEIVABLES>                                   30,847
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               358,070
<PP&E>                                          57,106
<DEPRECIATION>                                (23,799)
<TOTAL-ASSETS>                                 417,818
<CURRENT-LIABILITIES>                           24,081
<BONDS>                                        220,092
                                0
                                         23
<COMMON>                                           549
<OTHER-SE>                                     172,154
<TOTAL-LIABILITY-AND-EQUITY>                   417,818
<SALES>                                              0
<TOTAL-REVENUES>                                36,481
<CGS>                                                0
<TOTAL-COSTS>                                   30,938
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               4,704
<INCOME-PRETAX>                                  1,479
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                              1,479
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     1,479
<EPS-BASIC>                                     (0.04)
<EPS-DILUTED>                                   (0.04)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission